Mobile Health Application of Screening and Early Intervention for Prediabetic Patient at Primary Health Cares Setting

NCT ID: NCT04979559

Last Updated: 2021-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

350 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-25

Study Completion Date

2021-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Preventing type-2 diabetes mellitus begins with early screening and intervention of prediabetic participants. Until now, prediabetes screening and early intervention have not been optimal. The rapid advancement of technology, as well as its increased use, may provide an opportunity to improve the quality and cost of healthcare services. It is quite practicable to investigate and implement a valid, practical and easy-to-use mobile health application for participants and health staffs in screening and early intervention of prediabetes participants at primary health cares setting. This protocol aimed to identify and develop a valid, practical, and easy-to-use mobile health application for screening and early intervention of prediabetes participants at primary health cares.

Methods: This protocol was prepared in accordance with the Standard Protocol Items: Recommendations for Interventional Trials 2013 statement. This is a mixed-methods study with sequential exploratory approach. This project will begin with in-depth interview to gather qualitative information regarding mobile health application necessity for prediabetes participants at the primary health cares. The impact of the usage will be studied quantitatively using randomized controlled trial. Prediabetic participants and primary health cares staffs at Yogyakarta province will be the research subjects. The collected findings will be examined based on the type of the data.

Discussion: The proposed research aimed to obtain information and trial results regarding mobile health application usage for prediabetes participants screening and early intervention at primary health cares setting.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this study is to create a mobile health application for prediabetes patients that included screening and early intervention in Primary Health Cares (PHCs) setting. More specifically, the objectives are as follows:

1. To portray regular prediabetes screening and early intervention practice in PHCs.
2. To assess prediabetes screening and early intervention data necessity for mobile health application model at PHCs.
3. To assess the feasibility of mobile health application usage for screening and early intervention of prediabetes patients at PHCs.
4. To assess internal and external factors that influence the intention-to-use, easiness, and usefulness of mobile health applications for prediabetes patients and health staff.
5. To assess the impact of early intervention using mobile health applications on prediabetes patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PreDiabetes Prediabetic State

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be assigned to one of two arms: (1) a group that is used mobile health application intervention for screening and early intervention and (2) a group that receive standard care for screening and early intervention from PHCs regular practice.
Primary Study Purpose

SCREENING

Blinding Strategy

DOUBLE

Participants Caregivers
The participant and care provider in each site are unaware of the group allocation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

mHealth apps

The participants in this arm will receive information regarding mobile health applications used for screening and early intervention of the prediabetic states.

Group Type EXPERIMENTAL

Mobile health apps

Intervention Type DEVICE

Mobile health application intervention including screening and early intervention such as diet and physical activity suggestion

Standard care

The participant in this arm will receive regular practice or standard care of screening and early intervention of prediabetic state.

Group Type ACTIVE_COMPARATOR

Standard care

Intervention Type OTHER

Regular practice for screening and early intervention for prediabetes patient in primary health cares setting

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mobile health apps

Mobile health application intervention including screening and early intervention such as diet and physical activity suggestion

Intervention Type DEVICE

Standard care

Regular practice for screening and early intervention for prediabetes patient in primary health cares setting

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosed as the prediabetic state using American Diabetes Association (ADA) criteria
* have no previous diagnosis of type 2 diabetes or history of taking anti-hyperglycemic drugs
* have access to and able to use a personal smartphone
* willing to undertake study activities and written informed consent

Exclusion Criteria

* severe medical condition
* disability to perform physical activity
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitas Islam Indonesia

UNKNOWN

Sponsor Role collaborator

Gadjah Mada University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yaltafit Abror Jeem

Principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yaltafit A Jeem

Role: PRINCIPAL_INVESTIGATOR

Gadjah Mada University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kalasan PHC

Sleman, Special Region of Yogyakarta, Indonesia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Indonesia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yaltafit A Jeem

Role: CONTACT

+62 856-4366-1294

Russy N Andriani

Role: CONTACT

+6287821562151

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yaltafit A Jeem

Role: primary

+62 856-4366-1294

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KE/FK/1375/EC/2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mastering Diabetes Study
NCT04454957 ACTIVE_NOT_RECRUITING NA